Aberdeen Group’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.7M Buy
1,031,201
+800,456
+347% +$7.53M 0.02% 603
2025
Q1
$1.25M Hold
230,745
﹤0.01% 798
2024
Q4
$1.72M Buy
+230,745
New +$1.72M ﹤0.01% 774